ArticleOncoimmunology

Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model.

Jaquelyn T Zoine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.